Zydus Nikkho Farmaceutica Ltda Pharmaceutical Import Profile — Brazil (DGFT 2022–2026)

Name: Zydus Nikkho Farmaceutica Ltda Pharmaceutical Import Records from India — 2 Products, $1.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Zydus Nikkho Farmaceutica Ltda — Pharmaceutical Importer Profile (2026) | 2 Products, $1.2M Trade | TransData Nexus

Zydus Nikkho Farmaceutica Ltda

Pharmaceutical Importer · Brazil · Cardiovascular Focus · $1.2M Total Trade · DGFT Verified

Zydus Nikkho Farmaceutica Ltda is a pharmaceutical importer based in Brazil with a total trade value of $1.2M across 2 products in 1 therapeutic categories. Based on 39 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Zydus Nikkho Farmaceutica Ltda sources from 3 verified Indian suppliers, with Zydus Lifesciences Limited accounting for 96.5% of imports.

Zydus Nikkho Farmaceutica Ltda — Import Portfolio & Supplier Network

Zydus Nikkho Farmaceutica Ltda import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Zydus Nikkho Farmaceutica Ltda?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Zydus Lifesciences Limited	$13.9M	685	96.5%
Cadila Healthcare Limited	$496.7K	16	3.5%
Caplin Steriles Limited

What Formulations Does Zydus Nikkho Farmaceutica Ltda Import?

Formulation	Value	Ships
Pharma drugs & medicine-divalproex sodiu	$327.3K	9
Pharma drugs & medicine:divalproex sodiu	$225.1K	7
Pharma drugs & medicine-topiramate	$215.9K	5
Tamsulosin hcl pr TAB 0.4MG 30 sale	$193.4K	9
Pharma drugs & medicine-quetiapine	$150.0K	3
Pharma drugs & medicine:paroxetine	$146.6K	3
Pharmaceuticals medicine for human use-lamotrigine tabs USP 100MG 30's sale brz(lamotrigine) 2x15 qty-103,337.000	$139.4K	3
Pharma drugs & medicine-trazodone hcl	$130.4K	4
Pharma drugs & medicine-sertraline	$124.1K	3
Pharmaceuticals medicine for human use-etoricoxib TAB 90MG 7's sale brazil (etoricoxib) 1x7 qty-117,720.000	$120.8K	3
Trazodone hcl TAB USP 100MG 30s sale	$113.5K	3
Pharma drugs & medicine-paracetamol	$109.3K	3
Isosorbide mononitrate tb BP 20MG 3x10 (isosorbide mononitrate) - serial nos .64521 to 64546, 64547 to 64547	$108.0K	6
Para(aceta)/trama tablets 325/37.5MG	$107.6K	3
Pharmaceuticals medicine for human use-paroxetine hydrochloride 20MG tabs (paroxetine hydrochloride)3x10 qty-140,847	$105.6K	3

Zydus Nikkho Farmaceutica Ltda imports 462 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Isosorbide	Cardiovascular	$997.3K	35	2.2%	8
2	Amiodarone	Cardiovascular	$200.0K	4	0.3%	18

Zydus Nikkho Farmaceutica Ltda imports 2 pharmaceutical products across 1 categories into Brazil totaling $1.2M.

Zydus Nikkho Farmaceutica Ltda — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Zydus Nikkho Farmaceutica Ltda is a Brazilian pharmaceutical company specializing in the wholesale distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established on June 27, 2008, in Rio de Janeiro, the company operates as a limited liability entity under the CNPJ number 05.254.971/0006-96. (cnpj.biz) It is a subsidiary of the multinational Zydus Group, which originated in India. The company began its journey in Brazil in 2004 and achieved a significant milestone in 2007 through the acquisition of Nikkho do Brasil, enhancing its portfolio with prescription products and generic drugs.

Zydus Nikkho Farmaceutica Ltda plays a pivotal role in Brazil's pharmaceutical distribution network by importing and distributing a diverse range of pharmaceutical products. Its operations are integral to ensuring the availability of essential medications across the country, thereby contributing to the healthcare sector's efficiency and effectiveness.

2Distribution Network

The company maintains a robust distribution network with multiple facilities across Brazil. Its primary operations are based in Rio de Janeiro, with additional facilities in São Paulo and Espírito Santo. These locations enable Zydus Nikkho Farmaceutica Ltda to effectively manage logistics and ensure timely delivery of pharmaceutical products throughout the country. The strategic positioning of these facilities facilitates efficient distribution and supports the company's commitment to meeting the healthcare needs of the Brazilian population.

3Industry Role

Zydus Nikkho Farmaceutica Ltda functions as a pharmaceutical importer and distributor within Brazil's supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures a steady supply of essential medications to the Brazilian market. Its role is crucial in bridging the gap between global pharmaceutical manufacturers and local healthcare providers, thereby enhancing the accessibility and affordability of medications for patients across Brazil.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Zydus Nikkho Farmaceutica Ltda

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with a significant reliance on a limited number of suppliers. Notably, Zydus Nikkho Farmaceutica Ltda imports the majority of its pharmaceutical products from Zydus Lifesciences Limited, accounting for approximately 96.5% of its total imports. This concentration suggests a strategic partnership aimed at ensuring consistent product quality and supply reliability. However, such dependency also poses potential risks, including supply chain disruptions due to geopolitical issues, regulatory changes, or operational challenges within the supplier's facilities. The company's limited diversification in sourcing could impact its ability to mitigate these risks effectively.

2Supply Chain Resilience

Zydus Nikkho Farmaceutica Ltda's supply chain resilience is closely tied to the stability and reliability of its primary supplier, Zydus Lifesciences Limited. The company's limited diversification in sourcing indicates a potential vulnerability to disruptions affecting this supplier. To enhance supply chain resilience, it would be prudent for the company to consider diversifying its supplier base and establishing relationships with additional manufacturers. This strategy would mitigate risks associated with over-reliance on a single supplier and ensure a more robust and adaptable supply chain capable of maintaining consistent product availability in the Brazilian market.

Importing Pharmaceuticals into Brazil — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Brazil

1Regulatory Authority & Framework

In Brazil, the National Health Surveillance Agency (ANVISA) is the primary regulatory authority overseeing the pharmaceutical sector. ANVISA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products available in the Brazilian market. The agency enforces regulations that govern the importation, registration, and commercialization of pharmaceutical products, ensuring compliance with national health standards. Key legislation includes the Health Surveillance Law (Law No. 9,782/1999), which established ANVISA, and the Brazilian Health Regulatory Framework, which outlines the procedures for drug approval and market authorization.

2Import Licensing & GMP

Import licensing in Brazil requires pharmaceutical companies to obtain authorization from ANVISA before bringing products into the country. This process involves submitting detailed documentation, including product information, manufacturing processes, and quality control measures. Additionally, imported pharmaceutical products must comply with Good Manufacturing Practice (GMP) standards recognized by ANVISA. ANVISA accepts GMP certifications from reputable international bodies, such as the European Medicines Agency (EMA), the World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that manufacturing processes meet international quality standards, thereby safeguarding public health.

Zydus Nikkho Farmaceutica Ltda — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Zydus Nikkho Farmaceutica Ltda's focus on cardiovascular medications, particularly isosorbide and amiodarone, aligns with the significant demand for treatments addressing heart conditions in Brazil. The prevalence of cardiovascular diseases in the country necessitates a steady supply of effective medications. By importing these specific therapeutic areas, the company addresses a critical healthcare need, positioning itself as a key player in improving cardiovascular health outcomes for the Brazilian population.

2Sourcing Profile

The company's sourcing strategy emphasizes the procurement of generic drugs, with a particular focus on formulations for cardiovascular treatments. India's robust pharmaceutical manufacturing capabilities and competitive pricing make it an attractive source for these products. By importing finished pharmaceutical formulations from India, Zydus Nikkho Farmaceutica Ltda leverages cost efficiencies while ensuring access to high-quality medications, thereby enhancing its competitive position in the Brazilian market.

3Market Positioning

Based on its product mix, Zydus Nikkho Farmaceutica Ltda primarily serves the wholesale distribution segment of the Brazilian pharmaceutical market. By importing and distributing essential medications, the company supplies products to various stakeholders, including retail pharmacies, hospitals, and healthcare providers. Its focus on cardiovascular medications positions it as a significant contributor to the treatment of heart conditions, thereby playing a vital role in the healthcare sector's overall functionality.

Seller's Guide — How to Become a Supplier to Zydus Nikkho Farmaceutica Ltda

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Zydus Nikkho Farmaceutica Ltda by offering alternative products or formulations that complement the existing portfolio. Diversifying the supplier base can enhance the company's supply chain resilience and reduce dependency on a single source. Additionally, introducing new products can address unmet needs in the Brazilian market, thereby expanding the company's reach and impact.

2Requirements & Qualifications

Indian exporters seeking to supply Zydus Nikkho Farmaceutica Ltda and the Brazilian market must ensure that their products comply with ANVISA's import licensing requirements. This includes obtaining GMP certifications from recognized authorities such as PIC/S. Additionally, products must meet ANVISA's quality control standards, including batch testing and stability studies. Labeling must be in Portuguese and adhere to ANVISA's guidelines, including the inclusion of QR codes for detailed product information.

3How to Approach

Frequently Asked Questions — Zydus Nikkho Farmaceutica Ltda

What products does Zydus Nikkho Farmaceutica Ltda import from India?

Zydus Nikkho Farmaceutica Ltda imports 2 pharmaceutical products across 1 categories. Top imports: Isosorbide ($997.3K), Amiodarone ($200.0K).

Who supplies pharmaceuticals to Zydus Nikkho Farmaceutica Ltda from India?

Zydus Nikkho Farmaceutica Ltda sources from 3 verified Indian suppliers. The primary supplier is Zydus Lifesciences Limited (96.5% of imports, $13.9M).

What is Zydus Nikkho Farmaceutica Ltda's total pharmaceutical import value?

Zydus Nikkho Farmaceutica Ltda's total pharmaceutical import value from India is $1.2M, based on 39 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Zydus Nikkho Farmaceutica Ltda focus on?

Zydus Nikkho Farmaceutica Ltda imports across 1 categories. The largest: Cardiovascular (100.0%).

Get Full Zydus Nikkho Farmaceutica Ltda Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.